| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Liu Dongfang | CHIEF MEDICAL OFFICER | C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK | /s/ Stephen Dang, Attorney-in-Fact | 03 Dec 2025 | 0001937915 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Class A Common Stock | Options Exercise | $439,500 | +150,000 | +833% | $2.93 | 168,000 | 01 Dec 2025 | Direct | |
| transaction | NUVB | Class A Common Stock | Sale | $1,173,255 | -150,000 | -89% | $7.82 | 18,000 | 01 Dec 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NUVB | Stock Option (Right to Buy) | Options Exercise | $0 | -150,000 | -48% | $0.000000 | 165,000 | 01 Dec 2025 | Class A Common Stock | 150,000 | $2.93 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.80 to $7.855. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| F2 | Option vested as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date |